CID 50940514

Androgen receptor antagonist 2

Structural Information

Molecular Formula
C21H15F5N4O2S
SMILES
CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=C(C(=C(C=C3)C#N)C(F)(F)F)F)C
InChI
InChI=1S/C21H15F5N4O2S/c1-20(2)18(32)29(14-7-4-10(9-27)15(16(14)23)21(24,25)26)19(33)30(20)11-5-6-12(13(22)8-11)17(31)28-3/h4-8H,1-3H3,(H,28,31)
InChIKey
CGRMNGGGSWLDDC-UHFFFAOYSA-N
Compound name
4-[3-[4-cyano-2-fluoro-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-fluoro-N-methylbenzamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

19
Patents

482.0836 Da
Monoisotopic Mass

3.7
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 483.09088 205.4
[M+Na]+ 505.07282 217.9
[M-H]- 481.07632 206.0
[M+NH4]+ 500.11742 213.7
[M+K]+ 521.04676 209.8
[M+H-H2O]+ 465.08086 187.7
[M+HCOO]- 527.08180 210.4
[M+CH3COO]- 541.09745 245.7
[M+Na-2H]- 503.05827 199.1
[M]+ 482.08305 197.7
[M]- 482.08415 197.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe